explore -WSS

explore

author：comprehensive 2025-09-28 18:30:37 - browse：3

Duchenne muscular dystrophy is a devastating disease and, until very recently, was one without much hope. When Hawken Miller was diagnosed at age 5, the physician told his parents to enjoy the time they had with him, as there wouldn’t be much. Over 20 years later, Miller is a journalist and content strategist for CureDuchenne, an organization started by his mother when he was diagnosed, and new treatment is on the horizon.

Last month, the FDA approved a new gene therapy from Sarepta Therapeutics that will provide hope for many patients and families. The new drug, however, has its limitations — it’s only approved for children age 4-5, for example. Miller joined the podcast to discuss how this drug may change lives, what more needs to happen, and what his personal experience has been living with Duchenne.

“For the older boys, we’re running up against the clock a little bit with what we’re able to do and what we’re not able to do,” Miller said. “And if we’re able to try anything that could possibly help, I think most people would like the opportunity to do that.”

The conversation is based off his recent First Opinion, “The FDA’s approval of a new gene therapy for Duchenne muscular dystrophy won’t help me — but it gives me hope.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Report: NIH

hotspot

WSS

Addiction doctors spar with methadone clinics over legislation

Caitlin Bernard's story shows physicians can't shy from advocacy

Providers still hesitate to prescribe buprenorphine, study finds

Caitlin Bernard's story shows physicians can't shy from advocacy

Addiction doctors spar with methadone clinics over legislation

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

knowledge

explore

knowledge

Virginia high school admissions case could be legal follow

Death toll from an explosion and collapse of a Paris building in June climbs to 3

How one medical school became remarkably diverse

Death toll from an explosion and collapse of a Paris building in June climbs to 3

ChatGPT in medicine: STAT answers readers' burning questions

Stigma and the return of syphilis

Bright Health sells Medicare Advantage business to Molina

Lab trade group sues FDA to halt regulation of lab

As demand for Covid shots wanes, Moderna seeks its next success

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

knowledge

Latest bird flu infection made farmworker sicker than earlier cases

Review: 'Barbie' will hit you like a shot in the heart

Prosthetic arm enables patients to feel the objects they grip

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

HIPAA doesn't protect reproductive records from prosecutors

Antibiotic resistance nearly killed me, so I'm raising awareness of it

hotspot

hotspot

leisure time

leisure time